February 22, 2021August 24, 2022
Enhertu Approved in UK for Inoperable, Advanced Breast Cancer
News
Enhertu (trastuzumab deruxtecan) has been granted conditional approval in the U.K. for the treatment of adults with inoperable or metastatic ... Read more
February 18, 2021February 18, 2021
Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC
News
An open-label Phase 2 clinical trial will test the safety and efficacy of IRX-2, an experimental immunology-based cancer therapy, in ... Read more
February 15, 2021February 15, 2021
Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer
News
Seagen’s Tukysa (tucatinib) has been approved by the European Commission (EC) as part of a triple-combination therapy for people with previously ... Read more
February 11, 2021February 11, 2021
Trial Testing AL101 in TNBC Doses First Patient
News
The first participant has been dosed in the Phase 2 clinical trial TENACITY, which is evaluating Ayala Pharmaceuticals‘ investigational therapy ... Read more
February 8, 2021February 8, 2021
‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer
News
After promising results from patients enrolled to date, Atossa Therapeutics halted an Australian Phase 2 clinical trial evaluating its investigative ... Read more
February 4, 2021February 4, 2021
Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors
News
Theralink Technologies announced that it has begun testing its new profiling biomarker assay — a test that could potentially provide ... Read more
February 1, 2021February 1, 2021
US Study Enrolling Women to Help Determine Best Screening Practices
News
A national study is seeking women in the U.S. to help determine the safest and best way to screen for ... Read more
January 28, 2021January 28, 2021
Nonprofit Highlights Importance of Global Teamwork for World Cancer Day
News
In honor of World Cancer Day on Feb. 4, the Breast International Group (BIG) emphasized the importance of wide-scale cooperation ... Read more
January 25, 2021January 25, 2021
Enhertu Approved in EU for Inoperable, Advanced Breast Cancer
News
The European Commission has conditionally approved Enhertu (trastuzumab deruxtecan) for adults in the EU with inoperable or metastatic HER2-positive breast cancer ... Read more
January 21, 2021January 21, 2021
Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA
News
Imagio, Seno Medical Instruments’ non-invasive and radiation-free breast imaging technology, has been approved for commercialization by the Center for Devices and ... Read more
January 18, 2021January 18, 2021
Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors
News
Mindfulness can significantly improve brain health and pain perception in breast cancer survivors, according to a small Canadian study. The ... Read more
January 14, 2021January 14, 2021
Genetic Test for Advanced Breast Cancer Launched in EU
News
Roche has launched a diagnostic genetic test to detect mutations in the PIK3CA gene in patients with advanced or metastatic ... Read more

April 3, 2019

FDA Proposes New Policies to Modernize, Improve Quality of Mammography Screenings

News

The U.S. Food and Drug Administration (FDA) has proposed a set of new policies to modernize and improve the quality of mammography screenings for breast cancer. The federal agency is ... Read more

April 2, 2019March 29, 2019

Doc, You’re a Downer. Let Me Revel in My 5-Year Mark

A Lump in the Road - A Column by Nancy Brier, Columns

I met a guy at a party. At first, he was quite the charmer, one of those middle-aged guys who was the most popular guy in high school. Standing within ... Read more

April 1, 2019

Breast Cancer Survivors Weigh in on Ways to Reduce the Financial Burden of the Disease

News

A qualitative study has proposed nine recommendations from breast cancer survivors about how to reduce the financial burden associated with the disease, which include changes to insurance, supportive services, financial ... Read more

March 29, 2019

Frying Oil Reheated Often, Like in Deep Frying, Seen to Promote Breast Cancer’s Spread in Animal Study

News

Frying oil that has repeatedly been reheated to high temperatures — as can take place in deep frying of foods — may cause genetic changes that trigger the growth and ... Read more

March 27, 2019

Molecular Patterns of Breast Cancer May Predict Chance of Relapse Up to 20 Years Later

News

Screening a woman’s breast cancer for certain genetic and molecular patterns may be used to predict the risk of the cancer returning (relapsing) up to 20 years later, a study ... Read more

March 25, 2019

Estrogen May Trigger Brain Metastasis in Triple-negative Breast Cancer, Study Shows

News

Estradiol, a type of estrogen and the major female hormone, may drive the spread of cancer to the brain in women with triple-negative breast cancer (TNBC), a study in mice ... Read more

March 22, 2019

AI Matches Radiologists’ Skill at Detecting Breast Cancer on Mammograms

News

An artificial intelligence (AI) system based on deep learning algorithms is able to detect breast cancer in digital mammography screenings as well as experienced radiologists, a study says. The findings ... Read more

March 20, 2019

CHMP Favors EU Approval of Lynparza for Some Advanced Breast Cancers

News

The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency (EMA), has recommended the approval of Lynparza (olaparib) tablets for the treatment of advanced breast ... Read more

March 19, 2019March 18, 2019

Reaching the Double Nickel

A Lump in the Road - A Column by Nancy Brier, Columns

I shivered in the parking lot at my kid’s school with four other moms. Originally, I planned to peel out of there before anyone could see me, but Leeanne caught ... Read more

March 18, 2019

Vitamin C Might Reverse Stress-induced Driver of Breast Cancer, Study Says

News

Chronic stress and the consequent release of the stress hormone epinephrine may help breast cancer cells grow by helping them get more energy, a study in mice shows. This effect might ... Read more

March 15, 2019

FDA Grants Accelerated Approval to Tecentriq-Abraxane Combo for Some TNBC

News

The U.S. Food and Drug Administration has granted accelerated approval to a combination of Tecentriq (atezolizumab) and the chemotherapy Abraxane (nab-paclitaxel) for patients with advanced triple-negative breast cancer, making this the ... Read more

March 13, 2019

Thousands of Lives Spared Thanks to Screening, Treatment, Study Reports

News

Since 1989, between 384,000 and 615,000 women’s lives have been spared thanks to significant advancements in breast cancer screening methods and treatment, a study reports. The findings of the study, ... Read more

Enhertu Approved in UK for Inoperable, Advanced Breast Cancer

Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC

Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer

Trial Testing AL101 in TNBC Doses First Patient

‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer

Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors

US Study Enrolling Women to Help Determine Best Screening Practices

Nonprofit Highlights Importance of Global Teamwork for World Cancer Day

Enhertu Approved in EU for Inoperable, Advanced Breast Cancer

Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA

Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors

Genetic Test for Advanced Breast Cancer Launched in EU